The bill amends existing laws regarding "Collaborative Pharmacy Practice" to expand the scope of collaborative practice agreements by allowing licensed pharmacists to collaborate not only with physicians but also with other healthcare providers. Key definitions are updated, including the replacement of "physicians" with "providers" in various contexts, and the introduction of a "written agreement" in place of "protocols." The bill emphasizes that collaborative practice agreements must be made in the best interest of public health, follow clinical guidelines and standards of care, and be reviewed and signed annually by the involved parties.

Additionally, the bill removes the definition of the "collaborative practice committee," which previously consisted of appointed individuals from pharmacy and medical boards to advise on collaborative practice agreements. It establishes that no approval or denial process is required for these agreements, allowing parties to begin acting pursuant to the agreement once all required documentation is complete. The bill also establishes immunity for the director of health, board members, and their agents from civil or criminal liability related to their official duties under this chapter. The changes are set to take effect on July 1, 2026.